PainReform (PRFX) Expected to Announce Earnings on Thursday

PainReform (NASDAQ:PRFX) is expected to release its earnings data before the market opens on Thursday, March 6th. Analysts expect PainReform to post earnings of ($4.74) per share for the quarter.

PainReform Trading Up 6.7 %

Shares of PainReform stock opened at $3.19 on Thursday. The company’s fifty day simple moving average is $3.48 and its two-hundred day simple moving average is $2.81. The company has a market cap of $462,550.00, a P/E ratio of -0.02 and a beta of 0.64. PainReform has a 12-month low of $1.73 and a 12-month high of $61.20.

PainReform Company Profile

PainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and second trial for pain treatment of hernia repair operations.